Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021

SELL
$86.23 - $125.19 $2.01 Million - $2.92 Million
-23,298 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$79.17 - $111.47 $31,509 - $44,365
-398 Reduced 1.68%
23,298 $2.09 Million
Q3 2020

Nov 12, 2020

BUY
$81.91 - $134.94 $990,619 - $1.63 Million
12,094 Added 104.24%
23,696 $2.45 Million
Q2 2020

Jul 30, 2020

BUY
$54.33 - $89.52 $630,336 - $1.04 Million
11,602 New
11,602 $917,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $232M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.